LYNSUNATE (Artemether 80mg/ml) IM INJECTION 1ml × 6 AMPOULES.

Rated 0 out of 5
(0 customer reviews)

Description: Lynsunate Injection contains Artemether, a potent antimalarial agent used for the treatment of severe malaria caused by Plasmodium falciparum. It acts by rapidly reducing the number of malaria parasites in the blood.

2,200.00

Hurry Up! Sales Ends In:

In stock

Category:

Guaranteed Safe Checkout

LYNSUNATE (Artemether 80mg/ml) IM INJECTION 1ml × 6 AMPOULES.
Brand Name: Lyn-edge Pharmaceuticals.
Generic Name: Artemether.
Class: Anti-malaria.
Pack Size: 6Amps.
Strength: 80mg/ml.
Amount: ₦2,200.

Description: Lynsunate Injection contains Artemether, a potent antimalarial agent used for the treatment of severe malaria caused by Plasmodium falciparum. It acts by rapidly reducing the number of malaria parasites in the blood.

Key features:
• Rapid Action: Quickly reduces the parasite load in severe malaria.
• High Efficacy: Effective in treating malaria, especially in regions with high drug resistance.
• Intramuscular Administration: Suitable for patients who cannot take oral medications.
• Convenient Dosage Form: Packaged in ampoules for accurate dosing.

Side effects.
• Pain or discomfort at the injection site, Dizziness, Nausea or vomiting, Abdominal pain, Headache
• In rare cases, allergic reactions such as rash, itching, or swelling

Caution:
• Allergic Reactions: Do not use if allergic to Artemether or any of the other ingredients.
• Administration: Should only be administered by a healthcare professional in a clinical setting.
• Medical Conditions: Inform your doctor if you have liver disease, kidney disease, or other medical conditions.
• Pregnancy & Breastfeeding: Consult a healthcare provider before use during pregnancy or breastfeeding.
• Drug Interactions: Inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Weight23 g

Reviews

There are no reviews yet.

Be the first to review “LYNSUNATE (Artemether 80mg/ml) IM INJECTION 1ml × 6 AMPOULES.”

Your email address will not be published. Required fields are marked *

Back To Top